|
|
|
41
|
7811AC
|
PROTRIDE 5MG TAB (HEA) FINASTERIDE
|
FINASTERIDE
|
PROTRIDE
|
3X10
|
A
|
6.82
|
0.2274
|
TAB
|
30
|
BOX
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
5 ALPHA REDUCTASE INHIBITORS
|
|
|
|
|
41
|
7811AE
|
FINASTERIDE 5MG TAB (FSB)
|
FINASTERIDE
|
FINASTERIDE
|
30'S
|
A
|
6.03
|
0.2012
|
TAB
|
30
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
5 ALPHA REDUCTASE INHIBITORS
|
|
|
|
|
42
|
7811AJ
|
PROTRIDE 5MG TAB (HEA) FINASTERIDE
|
FINASTERIDE
|
PROTRIDE
|
3X10
|
A
|
6.66
|
0.22
|
TAB
|
30
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
5 ALPHA REDUCTASE INHIBITORS
|
2025-10-31
|
|
|
|
42
|
7811AL
|
PROTRIDE 5MG TAB (HEA) FINASTERIDE
|
FINASTERIDE
|
PROTRIDE
|
3X10
|
A
|
6.69
|
0.22
|
TAB
|
30
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
CWS
|
CAPSULE WHOLESALE
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
5 ALPHA REDUCTASE INHIBITORS
|
2026-01-26
|
|
|
|
42
|
7811AM
|
PROTRIDE 5MG TAB (HEA) FINASTERIDE
|
FINASTERIDE
|
PROTRIDE
|
3X10
|
A
|
6.69
|
0.22
|
TAB
|
30
|
|
HEA
|
HEALTH 2000 INC
|
STO
|
BRYDEN STOKES LTD
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
5 ALPHA REDUCTASE INHIBITORS
|
2026-02-27
|
|
|
|
40
|
7811M
|
PMS-FINASTERIDE 5MG TAB (PMS/COL)
|
FINASTERIDE
|
PMS-FINASTERIDE
|
30'S
|
A
|
5.44
|
0.18
|
TABLET
|
30
|
TAB
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
7811P
|
PROTRIDE 5MG TAB (HEA/RXP) FINASTERIDE
|
FINASTERIDE
|
PROTRIDE
|
3X10
|
A
|
6.77
|
0.23
|
TABLET
|
30
|
TAB
|
HEA
|
HEALTH 2000 INC
|
RXP
|
RX PRO INC
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
7911AA
|
APO-CYCLOBENZAPRINE 10MG TAB (APO/COL)
|
CYCLOBENZAPRINE
|
APO-CYCLOBENZAPRINE
|
500'S
|
A
|
271.83
|
0.54
|
TABLET
|
42
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
122004
|
CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS
|
2022-04-01
|
2024-03-31
|
Package Size Change
|
Oral
|
6
|
AUTONOMIC DRUGS
|
2022-02-28
|
|
|
|
41
|
7911AB
|
APO-CYCLOBENZAPRINE 10MG TAB (APO)
|
CYCLOBENZAPRINE
|
APO-CYCLOBENZAPRINE
|
500'S
|
A
|
271.89
|
0.5438
|
TAB
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
122004
|
CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS
|
|
|
|
|
42
|
7911AC
|
APO-TIZANIDINE 4MG TAB (APO)
|
TIZANIDINE
|
APO-TIZANIDINE
|
100'S
|
A
|
9.65
|
0.10
|
TAB
|
21
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
122092
|
SKELETAL MUSCLE RELAXANTS, MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
SKELETAL MUSCLE RELAXANTS, MISCELLANEOUS
|
|
|
|
|
42
|
7911AF
|
NORGESIC 35MG|500MG TAB (GRM) ORPHENADRINE|PARACETAMOL
|
ORPHENADRINE|PARACETAMOL
|
NORGESIC
|
5X10
|
C
|
33.98
|
0.68
|
TAB
|
0
|
BLIS
|
GRM
|
GRIMANN S.A DE C.V.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
122092
|
SKELETAL MUSCLE RELAXANTS, MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
SKELETAL MUSCLE RELAXANTS, MISCELLANEOUS
|
|
|
|
|
41
|
7911Q
|
TIZANIDINE 4MG TAB (DRL)
|
TIZANIDINE
|
TIZANIDINE
|
150'S
|
A
|
17.51
|
0.1167
|
TAB
|
21
|
BOX
|
DRL
|
DR. REDDY'S LABORATORIES LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
40
|
7911R
|
NORGESIC 35MG | 500MG TAB (PMA/AHI) ORPHENADRINE | PARACETAMOL
|
ORPHENADRINE|PARACETAMOL
|
NORGESIC
|
10'S
|
C
|
7.07
|
0.71
|
TABLET
|
0
|
TAB
|
PMA
|
MORE PHARMA CORPORATION
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
122092
|
SKELETAL MUSCLE RELAXANTS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
7911R
|
NORGESIC 35MG|500MG TAB (PMA) ORPHENADRINE|PARACETAMOL (C)
|
ORPHENADRINE|PARACETAMOL
|
NORGESIC
|
10'S
|
C
|
8.15
|
0.8155
|
TAB
|
0
|
BOX
|
PMA
|
MORE PHARMA CORPORATION
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
122092
|
SKELETAL MUSCLE RELAXANTS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SKELETAL MUSCLE RELAXANTS, MISCELLANEOUS
|
|
|
|
|
40
|
7911T
|
TIZANIDINE 4MG TAB (KWA/ATB)
|
TIZANIDINE
|
TIZANIDINE
|
10X10
|
A
|
30.47
|
0.30
|
TABLET
|
21
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
42
|
7911W
|
CYCLOBENZAPRINE 10MG TAB (CIP)
|
CYCLOBENZAPRINE
|
CYCLOBENZAPRINE
|
100'S
|
A
|
10.41
|
0.10
|
TAB
|
42
|
BLIS
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
122004
|
CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS
|
|
|
|
|
40
|
7911Y
|
SIRDALUD 4MG TAB (BCH/COL) TIZANIDINE
|
TIZANIDINE
|
SIRDALUD
|
30'S
|
C
|
20.44
|
0.68
|
TABLET
|
0
|
TAB
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
7911Y
|
SIRDALUD 4MG TAB (BCH) TIZANIDINE (C)
|
TIZANIDINE
|
SIRDALUD
|
30'S
|
C
|
20.44
|
0.6814
|
TAB
|
21
|
BOX
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
42
|
7911Y
|
SIRDALUD 4MG TAB (BCH) TIZANIDINE
|
TIZANIDINE
|
SIRDALUD
|
30'S
|
C
|
23.24
|
0.77
|
TAB
|
21
|
BLIS
|
BCH
|
SANDOZ
|
COL
|
AVENTA BARBADOS
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
40
|
7912E
|
ORPHENADRINE 30MG/ML INJ (AKI/AHI)
|
ORPHENADRINE
|
ORPHENADRINE
|
10X2ML
|
C
|
690.07
|
69.01
|
INJECTION
|
0
|
AMP
|
AKI
|
AKORN INC.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
122092
|
SKELETAL MUSCLE RELAXANTS, MISCELLANEOUS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|